Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonino Picciotto

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Therapeutics and Clinical Risk Management|March 25, 2008
Antihepatitis C virus therapy in liver transplanted patientsAntonino Picciotto
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|November 9, 2004
[Budd-Chiari syndrome]Antonino Picciotto
Journal of Hepatology|May 2, 2002
Amantadine: a different approachFrancesco Torre, Antonino Picciotto
Cancer|May 11, 2005
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapyMonica Basso, Francesco Torre, Antonino Picciotto
Journal of Hepatology|September 21, 2014
A case of drug rash with eosinophilia and systemic symptoms (DRESS) induced by telaprevir associated with HHV-6 active infectionFrancesco Broccolo, Giulia Ciccarese, Antonino Picciotto, et al.
Digestive Diseases and Sciences|September 18, 2010
Predictive factors for response to peginterferon-alpha and ribavirin treatment of chronic HCV infection in patients aged 65 years and moreEdoardo G Giannini, Monica Basso, Vincenzo Savarino, et al.
Chest|July 8, 2010
Iodized oil pleural effusion in a patient previously treated with transarterial chemoembolization for hepatocellular carcinomaSimone Negrini, Gabriele Zoppoli, Enzo Andorno, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 21, 2006
Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis CNicoletta Pelli, Francesco Torre, Andrea Delfino, et al.
Membranes|January 27, 2021
MEMS Membranes with Nanoscale Holes for Analytical ApplicationsAlvise Bagolini, Raffaele Correale, Antonino Picciotto, et al.
Dermatology (Basel, Switzerland)|December 17, 2013
Pityriasis rosea in a hepatitis B-positive patient treated with pegylated interferon α2a: report of a case and review of the literatureFrancesco Drago, Sanja Javor, Linda Bruzzone, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Therapeutics and Clinical Risk Management|March 25, 2008
Antihepatitis C virus therapy in liver transplanted patientsAntonino Picciotto
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|November 9, 2004
[Budd-Chiari syndrome]Antonino Picciotto
Journal of Hepatology|May 2, 2002
Amantadine: a different approachFrancesco Torre, Antonino Picciotto
Cancer|May 11, 2005
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapyMonica Basso, Francesco Torre, Antonino Picciotto
Journal of Hepatology|September 21, 2014
A case of drug rash with eosinophilia and systemic symptoms (DRESS) induced by telaprevir associated with HHV-6 active infectionFrancesco Broccolo, Giulia Ciccarese, Antonino Picciotto, et al.
Digestive Diseases and Sciences|September 18, 2010
Predictive factors for response to peginterferon-alpha and ribavirin treatment of chronic HCV infection in patients aged 65 years and moreEdoardo G Giannini, Monica Basso, Vincenzo Savarino, et al.
Chest|July 8, 2010
Iodized oil pleural effusion in a patient previously treated with transarterial chemoembolization for hepatocellular carcinomaSimone Negrini, Gabriele Zoppoli, Enzo Andorno, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 21, 2006
Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis CNicoletta Pelli, Francesco Torre, Andrea Delfino, et al.
Membranes|January 27, 2021
MEMS Membranes with Nanoscale Holes for Analytical ApplicationsAlvise Bagolini, Raffaele Correale, Antonino Picciotto, et al.
Dermatology (Basel, Switzerland)|December 17, 2013
Pityriasis rosea in a hepatitis B-positive patient treated with pegylated interferon α2a: report of a case and review of the literatureFrancesco Drago, Sanja Javor, Linda Bruzzone, et al.
Pageof 4